Rafael Holdings, Inc. 13D and 13G filings for Cyclo Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2023-10-24 4:43 pm Purchase | 2023-10-20 | 13D | Cyclo Therapeutics, Inc. CYTH | Rafael Holdings Inc. RFL | 12,780,543 49.000% | 623,329 (+5.13%) | Filing |
2023-08-07 3:35 pm Purchase | 2023-07-31 | 13D | Cyclo Therapeutics, Inc. CYTH | Rafael Holdings Inc. RFL | 12,157,214 49.000% | 9,642,244 (+383.39%) | Filing |
2023-05-11 4:48 pm Purchase | 2023-05-02 | 13D | Cyclo Therapeutics, Inc. CYTH | Rafael Holdings Inc. RFL | 2,514,970 16.600% | 2,514,970 (New Position) | Filing |